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Introduction
To defend the integrity of the genome, cells have developed an 
extensive network of pathways that acts in concert to detect and 
signal DNA damage for subsequent processing and repair. The 
DNA damage–dependent delay in cell cycle progression criti-
cally depends on the phosphatidylinositol 3-kinaselike kinases 
(PIKKs) ataxia telangiectasia mutated (ATM) and ataxia telangi-
ectasia and Rad3 related (ATR). Whereas ATM signaling is 
predominantly activated by DNA double strand breaks (DSBs), 
which are triggered by ionizing radiation, ATR responds to a 
wider variety of DNA lesions, including UV-induced base dam-
age, replication stress, and DSBs (Shiloh, 2006; Cimprich and 
Cortez, 2008).
Key components of the ATM–ATR signaling pathway are 
the Chk2 and Chk1 kinases, which transmit the upstream signal 
to the downstream cell cycle proteins (Matsuoka et al., 1998; 
Liu et al., 2000). Triggering ATM–ATR signaling depends on 
several checkpoint mediator proteins such as 53BP1, MDC1, 
and TopBP1, which have been proposed to assist in promoting 
interactions between PIKKs and their substrates and/or aid the 
retention of critical factors in close proximity to DNA lesions 
(Bartek  and  Lukas,  2007).  In  the  ATR–Chk1  pathway,  the 
Rad9–Rad1–Hus1  complex  and  Claspin  are  additionally  re-
quired for Chk1 activation (Kumagai and Dunphy, 2000; Weiss 
et al., 2002). To delay cell cycle progression, Chk1 and Chk2 
are able to inhibit several isoforms of Cdc25, which are phos-
phatases that remove the inhibitory phosphorylation of cyclin–
Cdk complexes (Peng et al., 1997; Sanchez et al., 1997; Mailand 
et al., 2000). In contrast, Chk1 is also able to activate the tyro-
sine kinase Wee1, which phosphorylates and thereby inhibits 
the cyclin B–Cdk1 complex at the G2/M transition of the cell 
cycle (Lee et al., 2001). During the recovery from the DNA 
damage checkpoint, Claspin and Wee1 are degraded in an SCF-
TrCP1/2–dependent manner, and cell cycle progression is re-
sumed (Freire et al., 2006).
A common target of PIKKs is histone H2AX, which is 
phosphorylated on serine 139 (-H2AX; Rogakou et al., 1999). 
C
orrect replication of the genome and protection of 
its integrity are essential for cell survival. In a high-
throughput screen studying H2AX phosphoryla-
tion,  we  identified  Wee1  as  a  regulator  of  genomic 
stability. Wee1 down-regulation not only induced H2AX 
phosphorylation but also triggered a general deoxyribo-
nucleic acid (DNA) damage response (DDR) and caused a 
block  in  DNA  replication,  resulting  in  accumulation  of 
cells in S phase. Wee1-deficient cells showed a decrease 
in replication fork speed, demonstrating the involvement 
of Wee1 in DNA replication. Inhibiting Wee1 in cells 
treated with short treatment of hydroxyurea enhanced the 
DDR, which suggests that Wee1 specifically protects the 
stability  of  stalled  replication  forks.  Notably,  the  DDR   
induced by depletion of Wee1 critically depends on the 
Mus81-Eme1 endonuclease, and we found that codeple-
tion of Mus81 and Wee1 abrogated the S phase delay. 
Importantly, Wee1 and Mus81 interact in vivo, suggesting 
direct regulation. Altogether, these results demonstrate a 
novel role of Wee1 in controlling Mus81 and DNA repli-
cation in human cells.
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Results
Wee1 down-regulation triggers a DDR
To search for new genes controlling genome stability, we per-
formed a human kinome siRNA screen using -H2AX staining 
as a read out. Each kinase was down-regulated using a pool of 
four different siRNA oligonucleotides. The screen showed that 
down-regulation of Wee1 and Chk1 produces increased levels 
of -H2AX (Fig. S1 A). Wee1 is a well-known regulator of the 
cell cycle, but its role in maintaining genomic stability is much 
less well described. Therefore, we decided to focus our further 
studies on this kinase. First, the result obtained in the primary 
screen was validated by carrying out down-regulation of Wee1 
with each individual siRNA oligonucleotide of the siRNA pool 
used in the screen. Indeed, knocking down Wee1 with three out 
of the four siRNAs resulted in increased -H2AX staining, con-
firming that this phenotype is not a result of an off-target effect 
(Fig. S1 B). -H2AX antibody stained the nucleus homoge-
nously, similar to the staining observed in cells with DNA dam-
age during S phase (Fig. S1 C), and occurred as early as 24 h 
after the siRNA transfection, a time at which Wee1 is efficiently 
down-regulated (Fig. S1 D). This indicates that genomic integ-
rity, as measured by -H2AX staining, is dependent on Wee1.
Because the formation of -H2AX is dependent on ATR 
and ATM, we studied the effect of Wee1 down-regulation on 
other DDR proteins of both pathways to determine which one 
was activated. Immunofluorescence analyses demonstrated that 
Wee1 depletion resulted in characteristic DNA damage–induced 
foci of 53BP1 and MDC1, two mediators of the ATM pathway, 
and of replication protein A, TopBP1, and Rad9, which function 
in the ATR pathway (Fig. 1 A). These results indicate that a 
general DDR activation occurs in cells depleted of Wee1 and 
suggest that both double-stranded and single-stranded lesions 
are formed upon Wee1 depletion. A general activation of the 
DDR is also reflected by the phosphorylation of Smc1 and Nbs1 
in Wee1-depleted cells (Fig. 1 B). Interestingly, we observed   
a drop in protein levels of Chk1 upon down-regulation of Wee1, 
accompanied by a decrease in Claspin levels (Fig. 1 B). Further-
more, overexpression of a catalytic inactive version of Wee1 but 
not the wild-type form or treating cells with a Wee1 inhibitor 
induced strong phosphorylation of H2AX, demonstrating that 
the kinase activity of the protein is required to prevent the acti-
vation of a DDR (Fig. 1 C).
DDR induction by Wee1 deficiency occurs 
in S phase
In addition to a pronounced DDR, Wee1 depletion also resulted 
in a striking accumulation of cells in the S phase of the cell 
cycle (Fig. 2 A). Therefore, we wondered whether the DDR that 
is induced by depletion of Wee1 was occurring in this phase. By 
immunofluorescence analysis of cyclin A, which was not detected 
in G1 cells, moderately expressed in S phase, and highly expressed 
during G2, -H2AX staining induced by Wee1 depletion was 
mainly observed in S and G2 phases of the cell cycle (Fig. S1 E). 
Subsequent flow cytometry analysis showed that in the absence   
of Wee1, the majority of -H2AX–positive cells are in S phase   
(Fig. 2 B), confirming that depletion of Wee1 predominantly 
Upon the induction of DSBs, H2AX phosphorylation can be 
observed by its accumulation into nuclear foci that are thought 
to represent sites of DNA lesions. -H2AX focus formation 
was proposed to facilitate the recruitment of mediator proteins 
MDC1, RNF8, RNF168, 53BP1, BRCA1, and the Mre11–
Rad50–Nbs1 complex to sites of DNA damage, which is re-
quired both for signaling to DNA repair and promoting cell 
cycle  delay  (Jackson  and  Bartek,  2009;  van Attikum  and   
Gasser, 2009). -H2AX foci do not only quickly appear after 
the induction of DSBs, but phosphorylation of H2AX also 
occurs upon replication stress and treatment with other DNA-
damaging agents that do not directly induce DSBs, such as 
UV light (Burma et al., 2001; Ward and Chen, 2001; Stiff   
et al., 2004; Hanasoge and Ljungman, 2007). In the latter case, 
-H2AX staining is dependent on ATR and is mainly detected 
in S phase cells in which DSBs are believed to be the result of 
stalled replication forks (Ward and Chen, 2001; Hanasoge and 
Ljungman, 2007).
DNA replication is a tightly regulated process initiated by 
the association of origin recognition complex proteins to the 
DNA replication origins at telophase and early G1 followed by 
the loading of CDT1 and CDC6 proteins (Sclafani and Holzen, 
2007).  Then,  the  six  minichromosome  maintenance  (MCM) 
proteins (MCM2–7), which are thought to be the core of the 
replicative DNA helicase, are loaded onto the origins constitut-
ing the prereplication complexes. Activation of the S phase– 
promoting Cdks and Dbf4-dependent kinase then triggers the 
recruitment of replication factors such as Cdc45, replication 
protein A, GINS complex, and DNA polymerases to form func-
tional  bidirectional  replication  forks  (Sclafani  and  Holzen, 
2007). Cells have developed several mechanisms to monitor 
and solve perturbations during replication, for example when 
forks are blocked. In addition to their role in triggering a DNA 
damage response (DDR) upon DNA lesions during S phase, 
several  proteins  in  the ATR–Chk1  pathway  are  involved  in 
maintaining replication fork integrity when forks are temporally 
stalled (i.e., as a result of depletion of the deoxyribonucleoside 
triphosphate pool; Petermann and Caldecott, 2006). Also, pro-
teins involved in homologous recombination are important to 
repair DNA lesions that result in fork stalling (Heyer et al., 
2010). The heterodimeric Mus81-Eme1 structure-specific endo-
nuclease plays a critical role in the initial step of the repair by 
homologous recombination by cleaving the DNA at the stalled 
fork and temporally producing DSBs (Hanada et al., 2007). 
Other enzymes that have been implicated in resolving recombi-
nation intermediates are Blm, Gen1, and Exo1 (Segurado and 
Diffley, 2008; Wechsler et al., 2011).
Here, we set out to identify novel proteins controlling ge-
nomic stability by performing an siRNA screen of the human 
kinome. Wee1 down-regulation was found to induce high levels 
of -H2AX and a general activation of the DDR. Interestingly, 
Wee1-depleted cells accumulate in S phase and show a reduced 
replication speed. Notably, both the S phase progression delay 
and the DDR in the absence of Wee1 are dependent on Mus81-
Eme1, and Wee1 and Mus81 are interaction partners, demon-
strating a direct and previously unknown link between Wee1 
and Mus81.569 Wee1 inhibits the Mus81 endonuclease • Domínguez-Kelly et al.
levels were high in mitotic and early G1 cells of both control 
and Wee1-depleted cultures, an effect also observed in other 
studies (Ichijima et al., 2005; Quignon et al., 2007). However, 
down-regulation of Wee1 in cells progressing through mitosis 
and G1 did not additionally elevate -H2AX levels (Fig. 2 C). 
In contrast, upon progression through S phase, an increase in 
H2AX phosphorylation was specifically observed upon Wee1 
down-regulation (Fig. 2 D). Importantly, these higher -H2AX 
levels coincided with a delay in S phase progression as com-
pared with control down-regulated cells (Fig. 2 D, right).
triggers a DDR during S phase. Interestingly, Wee1-depleted 
cells that displayed intense -H2AX staining were not actively 
incorporating BrdU upon incubation for short time periods 
(Fig. S1 F). When incubating longer, BrdU-positive cells were 
observed both in Wee1–down-regulated and control cells, indi-
cating a slowdown but not a total inhibition of DNA synthesis 
(unpublished data).
To further demonstrate that the DDR activation in Wee1-
deficient cells occurs during S phase, cells were synchronized at 
different stages of the cell cycle. As shown in Fig. 2 C, -H2AX 
Figure 1.  Wee1 inhibition triggers a general DDR response. (A) Immunofluorescence analysis of U2OS cells transfected with siRNA oligonucleotides 
targeting Luciferase (Luc si) or Wee1 (Wee1 si) for 48 h or cells treated with etoposide (20 µM for 1 h) or UV light (40 J/m
2 for 1 h) as positive controls 
using the indicated antibodies. For every sample, a field with a similar amount of cells is shown. RPA, replication protein A. (B) Immunoblot analysis using 
cells treated as described in A. (C) U2OS cells were mock transfected or transfected with a wild-type (wt) or kinase-dead (kd; K328A) version of Flag-
Wee1 (top left and bottom) or treated with a Wee1 inhibitor for 4 h (top right). Thereafter, phosphorylation of H2AX was analyzed by immunoblot and 
immunofluorescence analysis. Bars, 10 µm.JCB • VOLUME 194 • NUMBER 4 • 2011   570
Figure 2.  Wee1 down-regulation affects cell cycle progression during S phase. (A) U2OS transfected with Luciferase siRNA (Luc si) or Wee1 siRNA (Wee1 
si) and cell cycle profiles were determined by flow cytometry analysis after staining with propidium iodide. (B) U2OS cells were transfected with Luciferase 
or Wee1 siRNA oligonucleotides. 48 h later, cells were fixed and analyzed by flow cytometry for -H2AX and DNA content by propidium iodide staining. 
(C and D) U2OS cells were transfected with the indicated siRNAs at the same time as they were synchronized with nocodazole (noc; C) or thymidine (thym; D) 
and were subsequently released from the arrest. At the indicated times after the release, cells were collected for flow cytometry analysis for propidium 
iodide staining or for analysis by Western blotting with the indicated antibodies. (E) Flow cytometry analysis for -H2AX/propidium iodide (right) or   
immunoblotting with the indicated antibodies (left) of U2OS cells transfected with Luc or Wee1 siRNA oligonucleotides and a control or Flag-Chk1 plasmid 
for 48 h.571 Wee1 inhibits the Mus81 endonuclease • Domínguez-Kelly et al.
To determine whether the decrease in fork speed observed 
in Wee1-depleted cells is directly responsible for the DDR acti-
vation, we treated U2OS cells with various concentrations of 
hydroxyurea (HU). Although treating cells with 5 µM HU led to 
a similar deceleration of replication fork speed as compared 
with Wee1 depletion, no significant elevation of -H2AX was 
observed (Fig. 4 A). This indicates that the DDR activation   
induced by depletion of Wee1 is not only a consequence of the 
decreased  replication  fork  speed.  Instead,  we  reasoned  that 
Wee1 could protect the stability of stalled replication forks. If 
this is the case, inhibiting Wee1 in the presence of short expo-
sure  to  HU  should  significantly  enhance  the  DDR.  Indeed, 
whereas treatment of the cells with HU or Wee1 inhibitor alone 
did not result in a notable increase in H2AX phosphorylation, 
combined treatment resulted in high levels of -H2AX by West-
ern blotting and an increased percentage of -H2AX–positive 
cells by immunofluorescence (Fig. 4 B).
Wee1 and Chk1 have complementing but 
distinct roles during DNA replication
As mentioned earlier in this section, a delay in DNA replication 
was reported in the absence of Chk1 (Maya-Mendoza et al., 
2007; Petermann et al., 2010). To study whether Wee1 and Chk1 
have separate functions in preventing genomic instability caused 
by replication problems, the effect of combined knockdown of 
Wee1  and  Chk1  on  -H2AX  induction  and  replication  fork 
speed was determined. Although simultaneous down-regulation 
of Wee1 and Chk1 did not increase -H2AX levels as compared 
with  single  knockdowns,  the  vast  majority  of  cells  without 
Wee1 and Chk1 undergo apoptosis, as judged by the sub-G1 
population by flow cytometry (Fig. 5 A). In addition, whereas 
Chk1 down-regulation slows down replication fork speed to a 
similar  extent  as  Wee1  knockdown,  combined  depletion  of 
Wee1 and Chk1 resulted in a significant decrease of replication 
fork speed (Fig. 5 B). Together, these results strongly suggest 
that Wee1 and Chk1 have separate but complementing roles in 
securing correct DNA replication.
DDR in the absence of Wee1 depends on 
the Mus81-Eme1 endonuclease
To study the cause of the decrease in replication fork speed, we 
monitored replication fork stability by examining levels of rep-
lication proteins and their ability to associate with chromatin. 
Among the components of the MCM2–7 complex studied, a re-
duced binding of the MCM4 subunit to the chromatin was ob-
served in Wee1-depleted cells as compared with control cultures, 
as demonstrated by immunofluorescence after a brief permeabi-
lization before fixation (Fig. S4 A) and chromatin fractionation 
(Fig. S4 B). Wee1 down-regulation did not affect the chromatin 
binding of MCM2, MCM5, or Cdc45, an initiation factor that 
interacts with the MCM complex (Fig. S4 B). To resolve whether 
the absence of MCM4 on chromatin could trigger a DDR, we 
down-regulated the MCM components MCM2 and MCM4 dur-
ing S phase. Indeed, depletion of MCM4, but not MCM2, re-
sulted in increased H2AX phosphorylation as compared with 
control cells (Fig. S4 C). Inhibition of replication upon MCM 
knockdown was also previously reported (Ibarra et al., 2008), 
DDR in the absence of Wee1 is dependent 
on Cdk2 but not Chk1 or Cdk1
Next, we investigated the basis of the DDR activation. As men-
tioned earlier in this section, we observed a decrease in Chk1 
protein levels upon Wee1 down-regulation (Fig. 1 B). Lack of 
Chk1 was reported to raise -H2AX levels in S phase cells 
(Syljuåsen  et  al.,  2005). Therefore,  we  determined  whether 
H2AX phosphorylation after Wee1 depletion was induced by low-
ering Chk1 levels. Overexpression of wild-type Chk1 could not 
prevent the appearance of -H2AX in Wee1-depleted cells nor in 
cells in which Wee1 is catalytically inhibited (Figs. 2 E and S2 A). 
Moreover, Wee1  knockdown  resulted  in  -H2AX  induction  at 
early time points after transfection, at which Chk1 levels are not yet 
affected. In contrast, phosphorylation of H2AX only occurs at late 
time points after Chk1 down-regulation (Fig. S2 B). Together, these 
data demonstrate that the DDR activation in Wee1-depleted cells 
cannot be explained by the drop in Chk1 levels.
As Wee1 is an important inhibitor of cyclin B–Cdk1 com-
plexes during G2 phase by phosphorylating Cdk1 on threonine 
14 and tyrosine 15, depletion of Wee1 was expected to result in 
overactivation of Cdk1, which might lead to activation of the 
DDR. Thus, we determined whether the lack of Cdk1 inhibition 
explains the DDR activation observed by studying the forma-
tion of -H2AX by Western blotting in Wee1- and/or Cdk1-
depleted cells that were synchronized in G1–S phase. In addition, 
cells were also transfected with siRNA against Cdk2, a key reg-
ulator in the initiation of DNA replication and continuation of 
DNA synthesis when associated with cyclins E or A, respec-
tively. Down-regulation of Cdk1 did not inhibit the generation 
of -H2AX in Wee1-depleted cells, indicating that overactiva-
tion of Cdk1 cannot explain the DDR observed in Wee1-depleted 
cells during S phase. However, depleting Cdk2 in Wee1–down-
regulated cells did abolish the DDR (Fig. S2 C). To address 
whether Wee1 influences the phosphorylation status of Cdk2 or 
Cdk1 during S phase, Cdk1 and Cdk2 inhibitory phosphoryla-
tion on tyrosine 15 was studied in synchronized S phase cells 
that  were  depleted  for Wee1.  Phosphorylation  of  Cdk1  and 
Cdk2 was inhibited in Wee1–down-regulated cells (Fig. S2 D), 
suggesting that Wee1 is capable of controlling Cdk1/2 by phos-
phorylating tyrosine 15 during S phase.
Wee1 controls replication fork movement
The aforementioned results suggest that Wee1 is important for 
DNA replication. To determine whether Wee1 plays a role dur-
ing DNA synthesis, we performed DNA combing experiments 
in  cells  successively  pulse  labeled  with  two  thymidine  ana-
logues,  which  permits  fork  speed  analysis  (Anglana  et  al., 
2003). The effect of Wee1 down-regulation was studied 24 and 
48 h after siRNA treatment. Interestingly, depletion of Wee1 
protein significantly decreased the mean replication fork speed 
from 2.16 to 1.25 kb/min early after Wee1 down-regulation, and 
this effect persisted at later time points (Fig. 3). To test whether 
Wee1  also  controls  replication  fork  movement  in  other  cell 
types, similar experiments were performed with lymphoblasts 
and fibroblasts. As shown in Fig. S3, down-regulation of Wee1 
in these cells produced a drop in replication fork speed similar 
to that observed in U2OS cells.JCB • VOLUME 194 • NUMBER 4 • 2011   572
was not able to revert the DDR induced by MCM4 depletion 
(Fig. S5 A), suggesting that Mus81 might act upstream of MCM4 
in generating the DDR. To further investigate this unexpected 
result, we depleted Mus81 in cells in which Wee1 was down-
regulated and examined MCM4 binding to chromatin in syn-
chronized S phase cells. Consequently, Mus81 down-regulation 
in Wee1-depleted cells was able to stabilize MCM4 at the chro-
matin (Fig. S5 B).
To demonstrate that the rescue of the DDR caused by 
Wee1 depletion by Mus81 is not a result of an indirect effect of 
preventing cells from entering S phase in the absence of Mus81, 
we monitored the progression of Mus81–down-regulated cells 
through S phase. In the absence of Mus81, cells were able to 
enter and progress through S phase as control cells, as is the 
case for cells depleted of Cdk2, the other protein we found to 
rescue the lack of Wee1 effect (Fig. S5 C).
Codepletion of Wee1 and Mus81 restores 
normal progression during S phase
Based on the aforementioned results, we speculated that Mus81 
might have a central and direct role in the S phase delay and 
DDR observed in Wee1-depleted cells. Therefore, the progres-
sion of synchronized S phase cells was studied in conditions of 
Wee1 and/or Mus81 down-regulation. As observed in Figs. 2 D 
and, therefore, we reasoned that Wee1 down-regulation could 
cause replication fork problems by depleting MCM4 from the 
chromatin, which subsequently triggers a DDR. However, sim-
ply decreasing replication fork speed is insufficient to enhance 
H2AX phosphorylation (Fig. 4 A), and, therefore, the activation 
of the DDR is unlikely to be directly caused by the defect in 
replication. Instead, we hypothesized that the DDR might be 
triggered by processing of the replication fork by a nuclease. 
Therefore, we tested whether the endonuclease Mus81-Eme1, 
which is known to process stalled replication forks (Hanada 
et al., 2007), could suppress the increase in H2AX phosphory-
lation induced by depletion of Wee1. Indeed, Mus81 depletion 
decreased the -H2AX signal in Wee1–down-regulated cells, 
indicating that its activity is critical for the DDR (Fig. 6 A). 
Fig. S4 (D and E) demonstrates that down-regulation of Exo1, 
Gen1, or Blm could not revert -H2AX induction triggered by 
Wee1 depletion, indicating that these enzymes are not involved 
in this response. In contrast, -H2AX levels are decreased upon 
the simultaneous down-regulation of Wee1 and Eme1 (Fig. S4 D), 
thereby confirming the role of the structure-specific endonucle-
ase Mus81-Eme1 in this process.
Next, we asked whether the H2AX phosphorylation pro-
duced by the lack of MCM4 could be suppressed by simultaneous 
down-regulation of Mus81. Surprisingly, Mus81 down-regulation 
Figure 3.  Fork movement slowdown by Wee1 depletion. U2OS cells were transfected with control (C) or Wee1 (Wee) siRNA oligonucleotides for the 
indicated times and thereafter pulsed for IdU and CldU. Fork speed was determined by measuring the length of IdU and CldU tracks on combed DNA mol-
ecules. Bar graphs show the percentages of molecules with certain replication speeds from one representative experiment. Above each graph, the average 
(Av) fork speed with the SEM of three independent experiments is indicated. Western blots show efficiency of Wee1 down-regulation.573 Wee1 inhibits the Mus81 endonuclease • Domínguez-Kelly et al.
Figure 4.  Wee1 protects the stability of stalled replication forks. (A) U2OS cells were treated with different concentrations of HU for 24 h. Thereafter, 
cells were pulsed for IdU and CldU and analyzed as described in Fig. 3 (top) or stained using the indicated antibodies for immunofluorescence (bottom).   
Av, average; PCNA, proliferating cell nuclear antigen. (B) U2OS cells were treated with Wee1 inhibitor. After 1 h, HU was added at the indicated concentra-
tions, and cells were harvested and analyzed by immunofluorescence for -H2AX or immunoblotting using the indicated antibodies. The graph represents 
the quantification of the immunofluorescence. Represented is the percentage of -H2AX–positive cells. A minimum of 1,000 cells was counted for each 
sample. Error bars represent the SEM of two independent experiments. Bars, 10 µm.JCB • VOLUME 194 • NUMBER 4 • 2011   574
Finally, to define the mechanism of how Mus81 is in-
volved in the DDR induced in the absence of Wee1, we deter-
mined whether Mus81 chromatin levels are affected by Wee1 
down-regulation. As shown in Fig. S5 E, no major changes in 
Mus81  association  to  the  chromatin  were  observed  in  both 
asynchronous cells and cells synchronized in S phase, arguing 
against the exclusion of Mus81 from the chromatin by Wee1. To 
demonstrate a possible direct link between Wee1 and Mus81, 
and 6 B, synchronized Wee1-depleted cells showed a pronounced 
inhibition of S phase progression. Interestingly, simultaneous 
down-regulation of Wee1 and Mus81 resulted in normal progres-
sion through S phase (Fig. 6 B), which, together with our previous 
results, suggests a functional relationship between these two pro-
teins. The strong accumulation of cells in S phase upon Wee1 
down-regulation in asynchronous cells was additionally allevi-
ated when Mus81 was depleted simultaneously (Fig. S5 D).
Figure 5.  Wee1 and Chk1 protect from replication problems in a different manner. (A) Flow cytometry analysis after propidium iodide staining (bottom) 
and immunoblot analysis (top) of U2OS cells transfected with Luc, Wee1, or Chk1 siRNA oligonucleotides or a combination for 48 h. (B) U2OS cells were 
transfected with Chk1 with or without Wee1 siRNA oligonucleotides for 48 h and thereafter pulsed for IdU and CldU. (bottom) Fork speed was determined 
by measuring the length of IdU and CldU tracks on combed DNA molecules. Bar graphs show the percentages of molecules with certain replication speeds 
from one representative experiment. Above each graph, the mean fork speed with the SEM of three independent experiments is indicated. (top) Levels of 
the indicated proteins by Western blotting.575 Wee1 inhibits the Mus81 endonuclease • Domínguez-Kelly et al.
immunoprecipitation experiments were performed. Upon over-
expression of both Wee1 and Mus81, the proteins coimmuno-
precipitated  (Fig.  7 A). An  interaction  between  endogenous 
Wee1 and Mus81 was also detected (Fig. 7 B). Together, these 
results indicate an unexpected new function of Wee1 and Mus81 
in S phase and suggest that changes in Wee1 function could   
affect genomic integrity.
Discussion
Here,  we  report  a  novel  function  of  Wee1  in  maintaining   
genomic stability by controlling the Mus81-Eme1 endonuclease 
during DNA replication. By performing a high-throughput siRNA 
screen to identify kinases involved in genome maintenance 
using -H2AX, a universal DDR marker, as a read out, we iden-
tified Wee1 with the highest score. Lack of Wee1 activates a gen-
eral DDR, predominantly in S phase cells. Wee1 down-regulation 
activates a Mus81-dependent DDR that slows down the replica-
tion fork speed.
In addition to Wee1, we also identified Chk1, an effector   
kinase in the ATR pathway, in the screen. Chk1 inhibition was re-
ported to cause an increase in -H2AX levels in other studies 
(Syljuåsen et al., 2005; Beck et al., 2010). Importantly, our results 
show that Wee1 depletion produces a decrease in Chk1 levels, but 
this is unlikely to account for the increase in -H2AX after Wee1 
down-regulation,  as  reintroduction  of  Chk1  in  Wee1-depleted 
cells did not prevent the DDR activation (Figs. 2 E and S2 A). 
Moreover, the decrease of Chk1 levels upon Wee1 down- 
regulation was not observed at early times after siRNA treatment, 
suggesting that is a side effect of the Wee1 down-regulation and/or 
the activated DDR (Fig. S2 B). As Chk1 was previously shown to 
activate Wee1 during the G2/M checkpoint (Lee et al., 2001) and 
the lack of Chk1 has a similar effect on the replication fork speed 
as Wee1 down-regulation, we down-regulated both Chk1 and Wee1 
to test whether they could be functioning together or in parallel 
pathways. Cell cycle profiles and measurements of DNA replica-
tion speed suggest that during replication, both proteins play a role 
in different pathways, as combined down-regulation results in 
more severe phenotypes than single knockdowns (Fig. 5).
Our results demonstrate an accumulation of cells with   
activated DDR in S phase and replication fork slowdown in the 
absence of Wee1. In addition, lack of Wee1 amplifies H2AX 
phosphorylation when replication is challenged (Fig. 4 B). 
Together, these results suggest that Wee1 protects the stability of 
stalled replication forks. Because the triggered DDR in replicating 
cells critically depends on Wee1 kinase activity (Fig. 1 C), cata-
lytic inhibitors of Wee1 might have potent antitumor potential. 
Indeed, recent publications show that a Wee1 inhibitor enhanced 
the cytotoxic effects of several DNA-damaging agents specifically 
in p53-deficient cell lines (Hirai et al., 2009, 2010). Our data sug-
gest that this anticarcinogenic effect could be achieved by the use 
of the inhibitor on its own and in all replicating cells.
With the exception of Chk1/Claspin levels, Wee1 depletion 
causes a global activation of the DDR, which indicates the pres-
ence of different types of DNA lesions, including DSBs (foci   
formation of 53BP1 and MDC1 and phosphorylation of Nbs1 and 
Smc1) and single-stranded lesions/stalled replication forks (foci 
Figure 6.  Mus81 knockdown rescues the DNA damage induction and S 
phase delay in the absence of Wee1. (A) U2OS cells were transfected with 
Luciferase or Mus81 siRNA (Mus81 si) for 48 h in the presence of thymidine 
(thym). During the last 24 h, they were transfected with Luciferase or Wee1 
siRNA (Wee1 si). After that, cells were released or not released from the 
thymidine block for 3 h before being lysed and analyzed with the indicated 
antibodies. (B) U2OS cells were transfected with Luciferase siRNA (Luc si) and 
Mus81 siRNA for 64 h and/or Wee1 siRNA oligonucleotides during the last 
24 h, all in the presence of thymidine. Cells were then released from the block 
and studied at the indicated times for DNA content by flow cytometry. West-
ern blot analysis with the indicated antibodies of whole-cell extracts at time 0 
is also shown. Dotted lines indicate the position of the G1 peak at t = 0.JCB • VOLUME 194 • NUMBER 4 • 2011   576
During the course of this project, two other papers ap-
peared describing the identification of Wee1 in an RNAi screen 
similar to ours (Beck et al., 2010; Murrow et al., 2010). Although 
the phenotypes observed in these studies are consistent with our 
work (i.e., Wee1 is required to maintain genomic stability), 
these studies provide limited insight into the mechanism by 
which Wee1 controls genomic integrity. Here, we demonstrate 
for the first time that Wee1 is controlling DNA replication and 
does so through controlling the Mus81 endonuclease. Although 
this effect seems independent of Cdk1, Cdk2 inhibition does 
formation of Rad9 and TopBP1). The magnitude of this DDR in 
the absence of Wee1 could be explained by the implication of 
Mus81 in the response upon Wee1 depletion. It is very likely that 
the endonuclease produces, in addition to DSBs, several other 
types of lesions by cleaving replication forks, as it shows high   
affinity for branched structures (Mazina and Mazin, 2008; Taylor 
and McGowan, 2008). This is in agreement with the 50× drop in 
cell viability upon Wee1 down-regulation compared with control 
cells but no additional sensitivity to other DNA-damaging agents 
such as UV light and ionizing radiation (unpublished data).
Figure 7.  Interaction between Wee1 and Mus81. 
(A) HEK 293T cells were cotransfected with the 
indicated combinations of plasmids including ex-
pression vectors for the wild-type (wt) or kinase-
dead  (kd;  K328A)  version  of  Flag-Wee1,  GFP, 
and  GFP-Mus81,  and  immunoprecipitations  (IP) 
using anti-GFP or anti-FLAG antibodies were per-
formed.  Inputs  and  immunoprecipitations  were 
analyzed  with  anti-Wee1  and  -GFP  antibodies. 
MM, molecular mass; WB, Western blot. (B) Immuno-
precipitations of endogenous Mus81 from U2OS 
cells analyzed by Western blotting using the in-
dicated antibodies. (C) A model for Wee1 regu-
lating DNA replication by controlling Mus81. See 
Discussion for details.577 Wee1 inhibits the Mus81 endonuclease • Domínguez-Kelly et al.
pTyr15-Cdk2 and Mus81 (Abcam); pSer317-Chk1 (Bethyl Laboratories, 
Inc.); -actin (Sigma-Aldrich); and mouse -H2AX and proliferating cell   
nuclear antigen (Millipore).
MCM2, MCM3, MCM4, MCM5, and Cdc45 antibodies were a gift 
from J. Méndez (Centro Nacional de Investigaciones Oncológicas, Madrid, 
Spain). Claspin, 53BP1, TopBP1, Rad9, and BLM antibodies were generated 
in-house and were previously described (Lee et al., 2001; Toueille et al., 2004; 
Semple et al., 2007; Rendtlew Danielsen et al., 2009). Selective Wee1 inhibitor 
II was purchased from EMD and used at 10 µM. For synchronization, cells were 
incubated with 2.5 mM thymidine for the time indicated in each experiment.
Transfection
The following siRNA oligonucleotides were used: Luciferase 5-UCG-
AAGUAUUCCGCGUACG-3 (Thermo Fisher Scientific), Wee1 #1   
5-AAUAGAACAUCUCGACUUA-3 (Thermo Fisher Scientific), Wee1 #2   
5-AAUAUGAAGUCCCGGUAUA-3 (Thermo Fisher Scientific), Wee1 #3   
5-GAUCAUAUGCUUAUACAGA-3 (Thermo Fisher Scientific), Wee1 #4   
5-CGACAGACUCCUCAAGUGA-3 (Thermo Fisher Scientific), MCM2 
5-UUCCAUGCCAUCUCCAAUGAGGCUCC-3  (Invitrogen),  MCM4 
(SMARTpool; Thermo Fisher Scientific), Mus81 5-CAGGAGCCAUC-
AAGAAUAA-3 (Invitrogen), Cdk1 5-GAUGUAGCUUUCUGACAAAAA-3 
(Thermo Fisher Scientific), Cdk2 5-UGCGAUAACAAGCUCCGUCC-3 
(Thermo Fisher Scientific), Chk1 #1 5-GCGUGCCGUAGACUGUCCA-3 
(Thermo Fisher Scientific), Chk1 #2 5-GCAACAGUAUUUCGGUAUA-3 
(Thermo Fisher Scientific), Gen1 5-GUAAAGACCUGCAAUGUUA-3 
(Thermo Fisher Scientific), Eme1 5-GGAUAAAGAACGCCAGAAU-3 
(Thermo Fisher Scientific), Exo1 5-CAAGCCUAUUCUCGUAUUU-3  
(Invitrogen), and BLM 5-UGCAAAUCACAUCGCUGCU-3 (Invitrogen).
In most experiments, Wee1 was down-regulated using oligonucleo-
tide #2. Cells were transfected using Lipofectamine RNAiMAX (Invitrogen) 
according to the manufacturer’s instructions. Metafectene Pro (Biontex) was 
used for siRNA and plasmid cotransfection experiments following the 
manufacturer’s guidelines.
Immunofluorescence
Cells grown on coverslips were washed in PBS, fixed with 2% PFA, perme-
abilized with 0.1% Triton X-100, and blocked using 1% FBS in PBS for   
1 h. The incubations of primary antibodies were performed by dilution in 
1% FBS for 1 h at RT. After a brief wash in 1% FBS, samples were incu-
bated with Alexa Fluor–conjugated secondary antibodies (Invitrogen). For 
preextraction, cells were washed in cytoskeletal buffer (10 mM Pipes, 
pH 7.0, 100 mM NaCl, 300 mM sucrose, and 3 mM MgCl2) and incu-
bated in cytoskeletal buffer supplemented with 0.5% Triton X-100 for 5 min 
on ice. Subsequently, cells were fixed using 2% PFA, washed in PBS, and 
extracted with cold methanol for 5 min. Then, samples were blocked and 
incubated with antibodies as described above.
BrdU incorporation was detected using the BrdU Labeling and Detec-
tion kit II (Roche) following the manufacturer’s recommendations. The mount-
ing medium used was Vectashield with DAPI (Vector Laboratories). Mounted 
slides were examined using a fluorescent microscope (Cell Observer) with 
20× NA 0.8 or 40× NA 1.3 magnification lenses and equipped with an 
AxioCam MR3 camera and AxioVision software (Carl Zeiss). Postacquisi-
tion image adjustments were performed using Photoshop (CS3; Adobe).
Chromatin fractionation
Biochemical fractionation of cells was performed essentially as previously 
described (Méndez and Stillman, 2000; Smits et al., 2006). Cells were 
washed in PBS and resuspended in solution A (10 mM Hepes, pH 7.9, 
10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, 
and protease and phosphatase inhibitors). Triton X-100 was added to a 
final concentration of 0.1%, cells were incubated on ice for 5 min, and the 
cytoplasmic (S1) and nuclear fractions were harvested by centrifugation at 
1,300 g for 4 min. Isolated nuclei were then washed in solution A, lysed 
in solution B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, and protease and 
phosphatase inhibitors), and incubated on ice for 10 min. The soluble nu-
clear (S2) and chromatin fractions were harvested by centrifugation at 
1,700 g for 4 min. Isolated chromatin (P2) was then washed in solution B, 
spun down at 10,000 g, and resuspended in Laemmli sample buffer. 
Fractions S1 and S2 were pooled to one soluble fraction. Protein concen-
trations were determined using the bicinchoninic acid protein assay, and 
equal amounts of protein were loaded.
Flow cytometry
For cell cycle analysis, cells were collected by trypsinization and fixed in 
70% ethanol at 4°C for a minimum of 2 h. After fixation, cells were washed 
with PBS, and the DNA was stained with propidium iodide.
rescue the DDR phenotype upon Wee1 depletion (Fig. S2 C). 
Interestingly, although Wee1 is a known Cdk1 regulator in G2/M, 
our data show that Wee1 is capable of controlling Cdk1/2 by 
phosphorylation at the beginning of S phase (Fig. S2 D).
Our results indicate that Wee1 critically regulates the Mus81-
Eme1 endonuclease, as depletion of Mus81 or Eme1 in Wee1–
down-regulated cells inhibits the DDR and most notably recovers 
a normal progression through S phase, demonstrating that Mus81 
plays a central role early during DNA replication (Figs. 6 and   
S4 D). This effect seems to be specific for Mus81-Eme1 but not 
for other endonucleases with similar functions such as Exo1 and 
Gen1 or Blm helicase, which has been described to be functionally 
and physically linked to the Mus81–Eme1 complex (Fig. S4, D 
and E). Human Mus81-Eme1 has been shown to cleave branched 
structures that resemble replication forks, nicked Holliday junc-
tions, and 3 flap extensions in vitro (Mazina and Mazin, 2008; 
Taylor and McGowan, 2008), implying that Mus81 might process 
similar intermediates arising during normal DNA replication   
in vivo. Controlling Mus81 activity during S phase might therefore 
be essential to prevent unscheduled DNA lesions.
How exactly Wee1 regulates Mus81 function is a remain-
ing and interesting issue. One possibility is that Wee1 controls 
directly or indirectly the association of Mus81 to the DNA, as it 
occurs in yeast with Cds1 (Kai et al., 2005), but Wee1 knock-
down does not affect the association of Mus81 to the chromatin 
(Fig. S5 E). Therefore, it is possible that Wee1 might negatively 
regulate the endonuclease activity by phosphorylation during 
DNA replication. The role of Cdk2 in this process might be ac-
tivation of Mus81 by phosphorylation. Hyperactivation of Cdk2   
in the absence of Wee1 might lead to an inappropriate increase 
in Mus81 activity, resulting in triggering a DDR (Fig. 7 C). 
Although more experiments need to be performed to address 
the molecular mechanism underlying Mus81 activation during 
S phase, our data showing an in vivo interaction between Wee1 
and the Mus81-Eme1 endonuclease implicate Wee1 in the 
direct inhibition of Mus81-Eme1 activity during S phase. Upon 
depletion of Wee1, this negative regulation is lost, likely result-
ing in deregulated dissection of replication forks by the endo-
nuclease, thereby triggering a DDR and an S phase delay.
Materials and methods
Cell lines and plasmids
U2OS and 293T cells, human lymphoblasts, and nontransformed HT1080 
fibroblasts were grown using standard procedures. The Flag-Chk1 plasmid 
was a gift from J. Bartek (Institute of Cancer Biology and Centre for Geno-
toxic Stress Research, Copenhagen, Denmark), and Flag-Gen1 was a gift 
from S. West (London Research Institute, Cancer Research UK, Clare Hall 
Laboratories, London, UK).
The coding sequence for human Wee1 was cloned in frame in pCMV 
Tag2B (Agilent Technologies) to generate a Flag-tagged version of Wee1. 
Flag-Wee1 kinase dead was obtained by site-directed mutagenesis of Flag-
Wee1 in which lysine 328 was changed to alanine using the QuikChange 
Site-Directed Mutagenesis kit (Agilent Technologies) with the primers 5-GAT-
GGATGCATTTATGCCATTCGACGATCAAAAAAGCCATTGGCG-3 and 
5-CGCCAATGGCTTTTTTGATCGTCGAATGGCATAAATGCATCCATC-3.
Antibodies and reagents
Antibodies obtained from commercial sources were as follows: cyclin A   
(H-432), Chk1 (G-4), Wee1 (B-11), Cdk1 (17), and Cdk2 (M2; Santa Cruz 
Biotechnology, Inc.); rabbit -H2AX, pSer957-Smc1, and pSer343-Nbs1 
(GenScript); pSer345-Chk1 and pTyr15-Cdk1 (Cell Signaling Technology); JCB • VOLUME 194 • NUMBER 4 • 2011   578
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-H2AX staining was performed as previously described (Huang 
and Darzynkiewicz, 2006) with slight modifications. In brief, cells were 
fixed in 70% ethanol overnight at 4°C. After washing with BSA-T-PBS (1% 
BSA/0.2% Triton X-100 in PBS), cells were incubated with mouse -H2AX 
antibody for 1 h at RT. After washing with BSA-T-PBS, cells were incubated 
with the FITC-conjugated secondary antibody and thereafter with propid-
ium iodide. The samples were analyzed by flow cytometry using an Epics 
XL-MCL (Beckman Coulter) or LSR II (BD) flow cytometer.
Automated analysis of genomic instability
Cells were grown in 96-well plates in 100 ml of culture medium and trans-
fected using HiPerFect transfection reagent (QIAGEN) according to the 
manufacturer’s guidelines. 48 h after transfection, cells were fixed with 3% 
formaldehyde, washed in PBS, and postfixed with cold methanol. To check 
the genomic instability, cells were stained with -H2AX antibody and DAPI. 
Image acquisition was performed using a Cellomics ArrayScan VTI (Thermo 
Fisher Scientific) with a 10× 0.50 NA objective, and five images were   
acquired per well, which contained 1,000–2,000 cells in total. Image 
analysis was performed using a high content screening reader (Cellomics 
ArrayScan). Cells were identified on the basis of DAPI staining and were 
scored for mean intensity per cell of -H2AX. All images and automated 
image quantifications were visually checked.
DNA combing and image acquisition
Combing was performed as previously described (Anglana et al., 2003). 
Cells were pulse labeled for 20 min with 100 mM IdU and for 20 min with 
100 mM CldU. Genomic DNA was prepared from DNA embedded in 
low-melting agarose blocks, and DNA fibers were combed on silanized 
coverslips. Neosynthesized DNA was immunodetected with mouse anti-
BrdU FITC (BD), rat anti-BrdU (AbD Serotec), Alexa Fluor 488–conjugated 
goat anti–mouse (Invitrogen), and Alexa Fluor 555–conjugated goat anti–
rat (Invitrogen). DNA fibers were detected with mouse anti–single-stranded 
DNA (Millipore), Cy5.5-conjugated goat anti–mouse, and Cy5.5-conjugated 
donkey anti–goat (Abcam). Slides were analyzed with an epifluorescence 
microscope (Axio Imager.Z2; Carl Zeiss) equipped with a 63× objective 
lens (NA 0.7–1.4) connected to a charge-coupled device camera (Cool-
SNAP HQ2; Roper Scientific), and MetaMorph software (Roper Scientific) 
was used for image acquisition.
Online supplemental material
Fig. S1 shows the kinome screen and its verifications. Fig. S2 demon-
strates that lower levels of Chk1 cannot account for the DDR in the ab-
sence of Wee1, but Cdk2 can. Fig. S3 shows replication fork speed upon 
Wee1 depletion in lymphoblasts and HT1080 cells. Fig. S4 demonstrates 
MCM4 protein by immunofluorescence and Western blot analysis after 
Wee1 knockdown as well as the effect of depletion of Eme1, Exo1, Gen1, 
and Blm proteins on the DDR in the absence of Wee1. Fig. S5 demon-
strates the effect of simultaneous knockdown of Mus81 and MCM4 or 
Wee1, the cell cycle effects of down-regulation of Mus81, Cdk2, Wee1,   
or  Mus81/Wee1,  and  Mus81  chromatin  levels  upon  Wee1  down- 
regulation. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201101047/DC1.
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